» Articles » PMID: 20036797

Taste Disorders in Cancer Patients: Pathogenesis, and Approach to Assessment and Management

Overview
Journal Oral Oncol
Publisher Elsevier
Specialty Dentistry
Date 2009 Dec 29
PMID 20036797
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Taste dysfunction in cancer patients impacts quality of life and impairs oral intake, which may have broader implications consisting of weight loss and nutritional compromise. These consequences may in turn affect broad symptom clusters including tissue healing, energy levels and mood. Patient evaluation and management should include a complete patient history and examination, and may require special tests. Patient-reported outcomes together with taste and smell testing are often necessary for diagnosis and management of taste disorders. Understanding, prevention and management of taste disorders in cancer patients requires continuing study. Current practice and recommendations are based on limited evidence. Due to its potentially significant impact on quality of life during and following cytotoxic therapy, and considering the increase in cancer survivorship, further research on this topic is imperative.

Citing Articles

Pharmacovigilance imbalance analysis of VEGFR-TKI-related taste and smell disorders.

Fu Z, Zhao C, Wang Y, Zhang L, Wang L Sci Rep. 2025; 15(1):3118.

PMID: 39856344 PMC: 11760945. DOI: 10.1038/s41598-025-87678-1.


Awareness of Contraindications Among Cancer Patients in Riyadh, Saudi Arabia: A Cross-Sectional Study.

Almuqbil M, Alobaid R, Alhamad A, Eddin N, Yahya N, Alsanie W Cancer Control. 2025; 32():10732748251313498.

PMID: 39825865 PMC: 11742164. DOI: 10.1177/10732748251313498.


Taste alterations after hematopoietic cell transplantation: a scoping review.

Dequae C, Raber-Durlacher J, Epstein J, de Vries R, Laheij A Support Care Cancer. 2024; 32(10):687.

PMID: 39320564 PMC: 11424654. DOI: 10.1007/s00520-024-08900-w.


Efficacy and Safety of Habitual Consumption of a Food Supplement Containing Miraculin in Malnourished Cancer Patients: The CLINMIR Pilot Study.

Lopez-Plaza B, Isabel Alvarez-Mercado A, Arcos-Castellanos L, Plaza-Diaz J, Ruiz-Ojeda F, Brandimonte-Hernandez M Nutrients. 2024; 16(12).

PMID: 38931260 PMC: 11207068. DOI: 10.3390/nu16121905.


Taste and Smell Alterations (TSAs) in Cancer Patients.

Rosati D, Mastino P, Romeo M, de Soccio G, Pentangelo D, Petrella C Diseases. 2024; 12(6).

PMID: 38920562 PMC: 11203271. DOI: 10.3390/diseases12060130.